GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus

Neurobiology of Disease

Volumn 37, Issue 2, 2010, Pages 314-323

  Andreou, Anna P ^a   Shields, Kevin G ^b   Goadsby, Peter J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

GABA; Migraine; Thalamus; Trigeminal; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; BICUCULLINE; GABAPENTIN; GLUTAMIC ACID; HYDROXYSACLOFEN; MUSCIMOL; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; MICROIONTOPHORESIS; MIGRAINE; NERVE CELL; NOCICEPTION; NONHUMAN; PH; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECORDING; SENSORY NERVE; THALAMUS;

AMINES; ANIMALS; ANTICONVULSANTS; CEREBRAL ARTERIES; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MIGRAINE DISORDERS; NEURAL INHIBITION; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SENSORY RECEPTOR CELLS; SYNAPTIC TRANSMISSION; TRIGEMINAL NERVE; VALPROIC ACID; VENTRAL THALAMIC NUCLEI;

EID: 72749115651     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.10.007     Document Type: Article

References (67)

1. Afridi S.K., and Goadsby P.J. Neuroimaging of migraine. Curr. Pain Headache Rep. 10 (2006) 221-224
2. Andlin-Sobocki P., Jonsson B., Wittchen H.U., and Olesen J. Cost of disorders of the brain in Europe. Eur. J. Neurol. 12 (2005) 1-27
3. Andreou A.P., Shields K.G., and Goadsby P.J. Sodium valproate but not gabapentin modulates trigeminovascular nociceptive transmission in the thalamus via GABAA receptor mechanisms: implications for migraine. Cephalalgia 29 (2009) 140
4. Angus-Leppan H., Olausson B., Boers P., and Lambert G.A. Convergence of afferents from superior sagittal sinus and tooth pulp on cells in the thalamus of the cat. Cephalalgia 15 (1995) 191-199
5. Armitage P., and Berry G. Statistical Methods in Medical Research (1994), Blackwell Science, Oxford
6. Bahra A., Matharu M.S., Buchel C., Frackowiak R.S.J., and Goadsby P.J. Brainstem activation specific to migraine headache. Lancet 357 (2001) 1016-1017
7. Bergerot A., Holland P.R., Akerman S., Bartsch T., Ahn A.H., MaassenVanDenBrink A., et al. Animal models of migraine. Looking at the component parts of a complex disorder. Eur. J. Neurosci. 24 (2006) 1517-1534
8. Bloom F.E. To spritz or not to spritz: the doubtful value of aimless iontophoresis. Life Sci. 14 (1974) 1819-1834
9. Bussone G., Diener H.C., Pfeil J., and Schwalen S. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blinded randomised controlled trials. Int. J. Clin. Pract. 59 (2005) 961-968
10. Cutrer F.M., Limmroth V., Ayata G., and Moskowitz M.A. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br. J. Pharmacol. 116 (1995) 3199-3204
11. DaSilva A.F., Becerra L., Makris N., Strassman A.M., Gonzalez R.G., Geatrakis N., et al. Somatotopic activation in the human trigeminal pain pathway. J. Neurosci. 22 (2002) 8183-8189
12. Davis K.D., and Dostrovsky J.O. Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus. Brain Res. 454 (1988) 89-100
13. Edwards K.R., Norton J., and Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 41 (2001) 976-980
14. Franks N.P., Dickinson R., de Sousa S.L., Hall A.C., and Lieb W.R. How does xenon produce anaesthesia?. Nature 396 (1998) 324
15. Franks N.P., and Lieb W.R. Molecular and cellular mechanisms of general anaesthesia. Nature 367 (1994) 607-614
16. Friedberg M.H., Lee S.M., and Ebner F.F. Modulation of receptive field properties of thalamic somatosensory neurons by the depth of anesthesia. J. Neurophysiol. 81 (1999) 2243-2252
17. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine-current understanding and treatment. New Eng. J. Med. 346 (2002) 257-270
18. Guieu R., Mesdjian E., Rochat H., and Roger J. Central analgesic effect of valproate in patients with epilepsy. Seizure 2 (1993) 147-150
19. Hering-Hanit R. Baclofen for prevention of migraine. Cephalalgia 19 (1999) 589-591
20. Hoskin K.L., Kaube H., and Goadsby P.J. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain 119 (1996) 1419-1428
21. Ipponi A., Lamberti C., Medica A., Bartolini A., and Malmberg-Aiello P. Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur. J. Pharmacol. 368 (1999) 205-211
22. Lee S.M., Friedberg M.H., and Ebner F.F. The role of GABA-mediated inhibition in the rat ventral posterior medial thalamus. I. Assessment of receptive field changes following thalamic reticular nucleus lesions. J. Neurophysiol. 71 (1994) 1702-1715
23. Lee S.M., Friedberg M.H., and Ebner F.F. The role of GABA-mediated inhibition in the rat ventral posterior medial thalamus. II. Differential effects of GABAA and GABAB receptor antagonists on responses of VPM neurons. J. Neurophysiol. 71 (1994) 1716-1726
24. Lee W.K., Limmroth V., Ayata C., Cutrer F.M., Waeber C., Yu X.Y., et al. Peripheral GABA-A receptor mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br. J. Pharmacol. 116 (1995) 1661-1667
25. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., and Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 (2001) 646-657
26. Loscher W. Valproate induced changes in GABA metabolism at the subcellular level. Biochem. Pharmacol. 30 (1981) 1364-1366
27. Loscher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16 (2002) 669-694
28. Loscher W., and Siemes H. Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia 26 (1985) 314-319
29. Loscher W., and Vetter M. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities. Biochem. Pharmacol. 34 (1985) 1747-1756
30. Mathew N.T., Kailasam J., Meadors L., Chernyschev O., and Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 40 (2000) 720-723
31. Mathew N.T., Rapoport A., Saper J., Magnus L., Klapper J., Ramadan N., et al. Efficacy of gabapentin in migraine prophylaxis. Headache 41 (2001) 119-128
32. Menken M., Munsat T.L., and Toole J.F. The global burden of disease study-implications for neurology. Arch. Neurol. 57 (2000) 418-420
33. Mesdjian E., DeFeudis F.V., Valli M., Jadot G., and Mandel P. Antinociceptive action of sodium valproate in the mouse. Gen. Pharmacol. 14 (1983) 697-699
34. Mulleners W.M., Chronicle E.P., Vredeveld J.W., and Koehler P.J. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur. J. Neurol. 9 (2002) 35-40
35. Nagler J., Conforti N., and Feldman S. Alterations produced by cortisol in the spontaneous activity and responsiveness to sensory stimuli of single cells in the tuberal hypothalamus of the rat. Neuroendocrinology 12 (1973) 52-66
36. Olausson B., Xu Z.Q., and Shyu B.C. Dorsal column inhibition of nociceptive thalamic cells mediated by gamma-aminobutyric acid mechanisms in the cat. Acta Physiol. Scand. 152 (1994) 239-247
37. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, London
38. Penfield W., and McNaughton F.L. Dural headache and the innervation of the dura mater. Arch. Neurol. Psychiatry 44 (1940) 43-75
39. Peschanski M., and Besson J.M. Diencephalic connections of the raphe nuclei of the rat brainstem: an anatomical study with reference to the somatosensory system. J. Comp. Neurol. 224 (1984) 509-534
40. Puppe A., and Limmroth V. GABAergic drugs for the treatment of migraine. CNS Neurol. Disord. Drug Targets 6 (2007) 247-250
41. Ray B.S., and Wolff H.G. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg. 41 (1940) 813-856
42. Reyes-Vazquez C., Enna S.J., and Dafny N. The parafasciculus thalami as a site for mediating the antinociceptive response to GABAergic drugs. Brain Res. 383 (1986) 177-184
43. Roberts W.A., Eaton S.A., and Salt T.E. Widely distributed GABA-mediated afferent inhibition processes within the ventrobasal thalamus of rat and their possible relevance to pathological pain states and somatotopic plasticity. Exp. Brain Res. 89 (1992) 363-372
44. Salt T.E. Gamma-aminobutyric acid and afferent inhibition in the cat and rat ventrobasal thalamus. Neuroscience 28 (1989) 17-26
45. Sawynok J., and LaBella F.S. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology 21 (1982) 397-403
46. Shields K.G., and Goadsby P.J. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?. Brain 128 (2005) 86-97
47. Shields K.G., Kaube H., and Goadsby P.J. GABA receptors modulate trigeminovascular nociceptive transmission in the ventroposteromedial (VPM) thalamic nucleus of the rat. Cephalalgia 23 (2003) 728
48. Shields K.G., Storer R.J., Akerman S., and Goadsby P.J. Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat. Neuroscience 135 (2005) 203-212
49. Shorvon S.D. Handbook of Epilepsy Treatment (2000), Blackwell Science Ltd, Oxford
50. Shosaku A., Kayama Y., Sumitomo I., Sugitani M., and Iwama K. Analysis of recurrent inhibitory circuit in rat thalamus: neurophysiology of the thalamic reticular nucleus. Prog. Neurobiol. 32 (1989) 77-102
51. Silberstein S.D. Divalproex sodium in headache: literature review and clinical guidelines. Headache 36 (1996) 547-555
52. Silberstein S.D., and Goadsby P.J. Migraine: preventative treatment. Cephalalgia 22 (2002) 491-512
53. Simpson K.L., Altman D.W., Wang L., Kirifides M.L., Lin R.C., and Waterhouse B.D. Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J. Comp. Neurol. 385 (1997) 135-147
54. Spira P.J., and Beran R.G. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61 (2003) 1753-1759
55. Steriade M., Jones E.G., and McCormick D.A. Thalamus (1997), Elsevier Science Ltd, Oxford
56. Stewart W.F., Ricci J.A., Chee E., Morganstein D., and Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 (2003) 2443-2454
57. Stone T.W. Microiontophoresis and pressure ejection. In: Smith A.D. (Ed). Methods in the Neurosciences 8 (1985), John Wiley and Sons, Chichester
58. 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 120 (1997) 2171-2177
59. Storer R.J., Akerman S., and Goadsby P.J. GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex. Br. J. Pharmacol. 134 (2001) 896-904
60. Storer R.J., Akerman S., Shields K.G., and Goadsby P.J. GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res. 1013 (2004) 188-193
61. Striano P., and Striano S. Gabapentin: a Ca2+ channel alpha 2-delta ligand far beyond epilepsy therapy. Drugs Today (Barc.) 44 (2008) 353-368
62. Vaught J.L., Pelley K., Costa L.G., Setler P., and Enna S.J. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology 24 (1985) 211-216
63. Westlund K.N., Sorkin L.S., Ferrington D.G., Carlton S.M., Willcockson H.H., and Willis W.D. Serotoninergic and noradrenergic projections to the ventral posterolateral nucleus of the monkey thalamus. J. Comp. Neurol. 295 (1990) 197-207
64. Yamashiro K., Mukawa J., Terada Y., Tomiyama N., Ishida A., Mori K., et al. Neurons with high-frequency discharge in the central nervous system in chronic pain. Stereotact. Funct. Neurosurg. 62 (1994) 290-294
65. Yamashiro K., Tomiyama N., Ishida A., Terada Y., Mukawa J., Yoshii Y., et al. Characteristics of neurons with high-frequency discharge in the central nervous system and their relationship to chronic pain. Experimental and clinical investigations. Stereotact. Funct. Neurosurg. 68 (1997) 149-154
66. Zagami A.S., and Lambert G.A. Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei of the cat. Exp. Brain Res. 81 (1990) 552-566
67. Zimmer R. Effects of sodium valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in men. Brain Res. Bull. 5 (1980) 585-588